Besides, heightened expression of GPC2 is linked to an increased risk of COPD, while increased expression of TESK2, AKR1A1, and MRC2 may result in an increased risk of spirometry-defined COPD. This evidence concerns the gene MRC2 and chronic obstructive pulmonary disease.